Scientific article

Swiss S1 guideline for the treatment of rosacea

Published inJournal of the European Academy of Dermatology and Venereology, vol. 31, no. 11, p. 1775-1791
Publication date2017

Rosacea (in German sometimes called 'Kupferfinne', in French 'Couperose' and in Italian 'Copparosa') is a chronic and frequently relapsing inflammatory skin disease primarily affecting the central areas of the face. Its geographic prevalence varies from 1% to 22%. The differential diagnosis is wide, and the treatment is sometimes difficult and varies by stage of rosacea. For erythematous lesions and telangiectasia, intense pulsed light (IPL) therapy and lasers are popular treatment option. In addition, a vasoconstrictor agent, brimonidine, has recently been developed. For papulopustular rosacea, topical antibiotics, topical and systemic retinoids, as well as systemic antibiotics are used. A topical acaricidal agent, ivermectin, has undergone clinical development and is now on the market. In the later stages, hyperplasia of the sebaceous glands develops, resulting in phymatous growths such as the frequently observed bulbous nose or rhinophyma. Ablative laser treatments have largely replaced classical abrasive tools. Here, we reviewed the current evidence on the treatment of rosacea, provide a guideline (S1 level) and discuss the differential diagnosis of rosacea.

  • Diagnosis
  • Differential
  • Humans
  • Practice Guidelines as Topic
  • Rosacea/diagnosis/epidemiology/pathology/therapy
  • Switzerland
Citation (ISO format)
ANZENGRUBER, F et al. Swiss S1 guideline for the treatment of rosacea. In: Journal of the European Academy of Dermatology and Venereology, 2017, vol. 31, n° 11, p. 1775–1791. doi: 10.1111/jdv.14349
Main files (1)
Article (Published version)
ISSN of the journal0926-9959

Technical informations

Creation08/09/2018 2:48:00 PM
First validation08/09/2018 2:48:00 PM
Update time03/15/2023 8:29:48 AM
Status update03/15/2023 8:29:47 AM
Last indexation01/17/2024 3:19:46 AM
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack